Randomized Phase III Study of Amcenestrant Plus Palbociclib Versus Letrozole Plus Palbociclib in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Primary Results from AMEERA-5

1. Cortés, J.
2. Hurvitz, S.A.
3. O'Shaughnessy, J.
4. Delaloge, S.
5. Iwata, H.
6. Rugo, H.S.
7. Neven, P.
8. Kanagavel, D.
9. Cohen, P.
10. Paux, G.
11. Cartot-Cotton, S.
12. Stefanova-Urena, M.
13. Deyme, L.
14. Aouni, J.
15. Sebastien, B.
16. Bardia, A.